Belite Bio (BLTE) Current Leases (2022 - 2025)

Belite Bio's Current Leases history runs 4 years deep, the most recent figure standing at $241000.0 for Q4 2025.

• On a quarterly basis, Current Leases fell 12.68% year-over-year to $241000.0 in Q4 2025; TTM through Dec 2025 was $241000.0, a 12.68% decrease from a year earlier, with the FY2025 full-year figure at $241000.0, down 12.68% from the prior year.
• Current Leases retreated to $241000.0 in Q4 2025 per BLTE's latest filing, from $265000.0 in the prior quarter.
• Across five years, Current Leases topped out at $308000.0 in Q4 2023 and bottomed at $198000.0 in Q4 2022.
• The 4-year median for Current Leases is $265000.0 (2025), against an average of $257600.0.
• Across the five-year window, Current Leases jumped 55.56% in 2023 and slipped 12.68% in 2025, its largest moves.
• Year by year, Current Leases stood at $198000.0 in 2022, then soared by 55.56% to $308000.0 in 2023, then retreated by 10.39% to $276000.0 in 2024, then declined by 12.68% to $241000.0 in 2025.
• Per Business Quant, the three latest BLTE Current Leases figures stand at $241000.0 (Q4 2025), $265000.0 (Q3 2025), and $276000.0 (Q4 2024).